← Back to Clinical Trials
Recruiting NCT06571227

NCT06571227 Establishing the Clinical Significance Values of the Lysholm Knee Score

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06571227
Status Recruiting
Phase
Sponsor Kırklareli University
Condition Knee Injuries
Study Type OBSERVATIONAL
Enrollment 69 participants
Start Date 2025-01-06
Primary Completion 2027-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Anterior cruciate ligament reconstruction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 69 participants in total. It began in 2025-01-06 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about patients who will undergo anterior cruciate ligament reconstruction. The main questions it aims to answer are: * What is the minimal clinically important difference value of the Lysholm Knee Score? * What is the substantial clinical benefit value of the Lysholm Knee Score? * What are the risk factors that prevent patients who have undergone anterior cruciate ligament reconstruction from reaching the minimal clinically important difference value? * What are the risk factors that prevent patients who have undergone anterior cruciate ligament reconstruction from reaching the substantial clinical benefit value?

Eligibility Criteria

Inclusion Criteria: * to be over 18 years old * to undergo surgery for a ruptured anterior cruciate ligament Exclusion Criteria: * to have metabolic or autoimmune diseases * to undergo revision anterior cruciate ligament surgery or anterior cruciate ligament repair * to have cognitive issues that will hinder the completion of the study forms * to lack sufficient proficiency in Turkish

Contact & Investigator

Central Contact

Ozan Gür, MSc

✉ ozan.gur94@gmail.com

📞 +90 506 338 38 49

Principal Investigator

Ozan Gür, MSc

PRINCIPAL INVESTIGATOR

Kırklareli University

Frequently Asked Questions

Who can join the NCT06571227 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06571227 currently recruiting?

Yes, NCT06571227 is actively recruiting participants. Contact the research team at ozan.gur94@gmail.com for enrollment information.

Where is the NCT06571227 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06571227 clinical trial?

NCT06571227 is sponsored by Kırklareli University. The principal investigator is Ozan Gür, MSc at Kırklareli University. The trial plans to enroll 69 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology